MYO Fundamental Analysis - MYOMO INC

Fundamental Rating

Taking everything into account, MYO scores 3 out of 10 in our fundamental rating. MYO was compared to 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of MYO have multiple concerns. MYO is valued quite expensively, but it does show have an excellent growth rating.

Quickly go to:

1. Profitability

1.1 Basic Checks

MYO had negative earnings in the past year.

MYO had a negative operating cash flow in the past year.

In the past 5 years MYO always reported negative net income.

MYO had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

MYO's Return On Assets of -24.11% is in line compared to the rest of the industry. MYO outperforms 48.92% of its industry peers.

MYO has a Return On Equity of -52.93%. This is comparable to the rest of the industry: MYO outperforms 50.54% of its industry peers.

		Industry Rank	Sector Rank
ROA	-24.11%
ROE	-52.93%
ROIC	N/A

ROA(3y)-58.67%

ROA(5y)-62.8%

ROE(3y)-94.75%

ROE(5y)-92.3%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MYO's Gross Margin of 69.24% is fine compared to the rest of the industry. MYO outperforms 75.81% of its industry peers.

In the last couple of years the Gross Margin of MYO has grown nicely.

MYO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	69.24%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.45%

GM growth 5Y2.49%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MYO does not have a ROIC to compare to the WACC, probably because it is not profitable.

MYO has more shares outstanding than it did 1 year ago.

The number of shares outstanding for MYO has been increased compared to 5 years ago.

There is no outstanding debt for MYO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -2.14, we must say that MYO is in the distress zone and has some risk of bankruptcy.

MYO has a Altman-Z score of -2.14. This is in the lower half of the industry: MYO underperforms 60.75% of its industry peers.

A Debt/Equity ratio of 0.22 indicates that MYO is not too dependend on debt financing.

MYO has a Debt to Equity ratio (0.22) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	N/A
Altman-Z	-2.14

ROIC/WACCN/A

WACC8.78%

2.3 Liquidity

A Current Ratio of 2.39 indicates that MYO has no problem at all paying its short term obligations.

MYO's Current ratio of 2.39 is in line compared to the rest of the industry. MYO outperforms 47.85% of its industry peers.

A Quick Ratio of 2.03 indicates that MYO has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 2.03, MYO is in line with its industry, outperforming 55.38% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.39
Quick Ratio	2.03

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for MYO have decreased strongly by -26.09% in the last year.

MYO shows a strong growth in Revenue. In the last year, the Revenue has grown by 69.17%.

MYO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 53.36% yearly.

EPS 1Y (TTM)-26.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-200%

Revenue 1Y (TTM)69.17%

Revenue growth 3Y32.93%

Revenue growth 5Y53.36%

Sales Q2Q%9.59%

3.2 Future

Based on estimates for the next years, MYO will show a very strong growth in Earnings Per Share. The EPS will grow by 30.48% on average per year.

Based on estimates for the next years, MYO will show a very strong growth in Revenue. The Revenue will grow by 24.42% on average per year.

EPS Next Y-117.45%

EPS Next 2Y-31.26%

EPS Next 3Y-3.2%

EPS Next 5Y30.48%

Revenue Next Year32%

Revenue Next 2Y24.53%

Revenue Next 3Y23.5%

Revenue Next 5Y24.42%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYO. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MYO. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

MYO's earnings are expected to decrease with -3.20% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-31.26%

EPS Next 3Y-3.2%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for MYO!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

MYOMO INC

NYSEARCA:MYO (12/26/2025, 8:04:33 PM)

After market: 1.01 -0.01 (-0.98%)

1.02

0 (0%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)11-10 2025-11-10/amc

Earnings (Next)03-09 2026-03-09/amc

Inst Owners50.39%

Inst Owner Change-10.87%

Ins Owners7.33%

Ins Owner Change2.71%

Market Cap39.21M

Revenue(TTM)32.55M

Net Income(TTM)-9.32M

Analysts80

Price Target5.1 (400%)

Short Float %9.68%

Short Ratio2.55

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-3.48%

Min EPS beat(2)-4.22%

Max EPS beat(2)-2.75%

EPS beat(4)2

Avg EPS beat(4)18.06%

Min EPS beat(4)-4.22%

Max EPS beat(4)50.5%

EPS beat(8)4

Avg EPS beat(8)17.38%

EPS beat(12)7

Avg EPS beat(12)14.73%

EPS beat(16)10

Avg EPS beat(16)13.79%

Revenue beat(2)2

Avg Revenue beat(2)5.03%

Min Revenue beat(2)4.48%

Max Revenue beat(2)5.57%

Revenue beat(4)4

Avg Revenue beat(4)10.8%

Min Revenue beat(4)4.48%

Max Revenue beat(4)20.73%

Revenue beat(8)6

Avg Revenue beat(8)6.89%

Revenue beat(12)8

Avg Revenue beat(12)5.03%

Revenue beat(16)12

Avg Revenue beat(16)10.75%

PT rev (1m)-1.96%

PT rev (3m)-5.66%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-0.47%

EPS NY rev (1m)3.17%

EPS NY rev (3m)3.68%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-1.41%

Revenue NY rev (1m)-0.5%

Revenue NY rev (3m)-1.29%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.96
P/FCF	N/A
P/OCF	N/A
P/B	2.23
P/tB	2.23
EV/EBITDA	N/A

EPS(TTM)-0.29

EYN/A

EPS(NY)-0.29

Fwd EYN/A

FCF(TTM)-0.33

FCFYN/A

OCF(TTM)-0.25

OCFYN/A

SpS1.06

BVpS0.46

TBVpS0.46

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-24.11%
ROE	-52.93%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	69.24%
FCFM	N/A

ROA(3y)-58.67%

ROA(5y)-62.8%

ROE(3y)-94.75%

ROE(5y)-92.3%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.45%

GM growth 5Y2.49%

F-Score3

Asset Turnover1.05

Health

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	850.82%
Cap/Sales	7.63%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.39
Quick Ratio	2.03
Altman-Z	-2.14

F-Score3

WACC8.78%

ROIC/WACCN/A

Cap/Depr(3y)269.1%

Cap/Depr(5y)214.88%

Cap/Sales(3y)1.88%

Cap/Sales(5y)1.72%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-26.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-200%

EPS Next Y-117.45%

EPS Next 2Y-31.26%

EPS Next 3Y-3.2%

EPS Next 5Y30.48%

Revenue 1Y (TTM)69.17%

Revenue growth 3Y32.93%

Revenue growth 5Y53.36%

Sales Q2Q%9.59%

Revenue Next Year32%

Revenue Next 2Y24.53%

Revenue Next 3Y23.5%

Revenue Next 5Y24.42%

EBIT growth 1Y1.56%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-79.42%

EBIT Next 3Y-1.11%

EBIT Next 5YN/A

FCF growth 1Y-71.9%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-31.3%

OCF growth 3YN/A

OCF growth 5YN/A

MYOMO INC / MYO FAQ

What is the fundamental rating for MYO stock?

ChartMill assigns a fundamental rating of 3 / 10 to MYO.

Can you provide the valuation status for MYOMO INC?

ChartMill assigns a valuation rating of 0 / 10 to MYOMO INC (MYO). This can be considered as Overvalued.

Can you provide the profitability details for MYOMO INC?

MYOMO INC (MYO) has a profitability rating of 2 / 10.

How financially healthy is MYOMO INC?

The financial health rating of MYOMO INC (MYO) is 3 / 10.

MYOMO INC (MYO) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

MYOMO INC / MYO FAQ

What is the fundamental rating for MYO stock?

Can you provide the valuation status for MYOMO INC?

Can you provide the profitability details for MYOMO INC?

How financially healthy is MYOMO INC?